“…These proteins include protein kinase C δ (PKC) [35,36] and c-Jun N-terminal kinase (JNK) [37,38,39]. In addition, other factors that regulate iNOS mRNA stability include transforming growth factor–β (TGF-β) [40,41], dexamethasone [42,43,44], 8-bromo-cyclic guanosine monophosphate (cGMP) [45,46], intracellular calcium elevating agents [47], forskolin (activates adenylate cyclase), dibutyryl cyclic adenosine monophosphate (cAMP) (membrane permeable cAMP analog) [48,49], tetrahydrobiopterin (BH4) [50,51], and L-arginine [52,53].…”